KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Synopsys (SNPS) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Synopsys (SNPS) over the last 17 years, with Q4 2025 value amounting to $3.0 billion.

  • Synopsys' Cash & Equivalents fell 2689.71% to $3.0 billion in Q4 2025 from the same period last year, while for Oct 2025 it was $3.0 billion, marking a year-over-year decrease of 2689.71%. This contributed to the annual value of $3.0 billion for FY2025, which is 2689.71% down from last year.
  • Latest data reveals that Synopsys reported Cash & Equivalents of $3.0 billion as of Q4 2025, which was down 2689.71% from $2.6 billion recorded in Q3 2025.
  • Synopsys' 5-year Cash & Equivalents high stood at $14.3 billion for Q2 2025, and its period low was $1.0 billion during Q1 2021.
  • Moreover, its 5-year median value for Cash & Equivalents was $1.5 billion (2023), whereas its average is $2.4 billion.
  • Within the past 5 years, the most significant YoY rise in Synopsys' Cash & Equivalents was 84764.29% (2025), while the steepest drop was 2689.71% (2025).
  • Synopsys' Cash & Equivalents (Quarter) stood at $1.4 billion in 2021, then dropped by 1.07% to $1.4 billion in 2022, then rose by 11.67% to $1.6 billion in 2023, then skyrocketed by 155.45% to $4.1 billion in 2024, then fell by 26.9% to $3.0 billion in 2025.
  • Its Cash & Equivalents stands at $3.0 billion for Q4 2025, versus $2.6 billion for Q3 2025 and $14.3 billion for Q2 2025.